Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 9, Issue 5

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Drug Safety, Volume 9, Issue 5 (2010)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 9, Issue 5 (2010)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Volume 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Original Research

Article

Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients

Andreas Holstein, Claude Hammer, Michael Hahn, Nidhi-Su-Ann Kulamadayil & Peter Kovacs

Pages: 675-681

Published online: 16 Jun 2010

AbstractforSevere sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients | Full Text | References | PDF (329.1 KB)

716 Views
63 CrossRef citations
0Altmetric

Reviews

Article

Long-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review

Fernando Cañas & Hans-Jürgen Möller

Pages: 683-697

Published online: 08 Aug 2010

AbstractforLong-acting atypical injectable antipsychotics in the treatment of schizophrenia: safety and tolerability review | Full Text | References | PDF (339.9 KB)

830 Views
24 CrossRef citations
0Altmetric

Article

QT prolongation in the intensive care unit: commonly used medications and the impact of drug–drug interactions

Pamela L Smithburger PharmD, Amy L Seybert PharmD, Michael J Armahizer PharmD & Sandra L Kane-Gill MS PharmD MSc FCCM

Pages: 699-712

Published online: 09 Apr 2010

AbstractforQT prolongation in the intensive care unit: commonly used medications and the impact of drug–drug interactions | Full Text | References | PDF (243.5 KB)

709 Views
23 CrossRef citations
0Altmetric

Article

Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development

Massimo Breccia MD & Giuliana Alimena

Pages: 713-721

Published online: 19 Aug 2010

AbstractforPleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development | Full Text | References | PDF (214.7 KB)

668 Views
16 CrossRef citations
0Altmetric

Article

Interactions between antifungal and antiretroviral agents

Christine A Hughes Bsc Pharm PharmD FCSHP, Michelle Foisy BSc Pharm PharmD FCSHP & Alice Tseng BSc Pharm PharmD FCSHP

Pages: 723-742

Published online: 29 Mar 2010

AbstractforInteractions between antifungal and antiretroviral agents | Full Text | References | PDF (276.9 KB)

303 Views
15 CrossRef citations
0Altmetric

Article

Therapeutic drug monitoring in highly active antiretroviral therapy

Xia Liu, Qing Ma & Fujie Zhang

Pages: 743-758

Published online: 30 Mar 2010

AbstractforTherapeutic drug monitoring in highly active antiretroviral therapy | Full Text | References | PDF (259.2 KB)

404 Views
25 CrossRef citations
0Altmetric

Article

Safety of amide local anesthetics: new trends

Regis Fuzier & Maryse Lapeyre-Mestre

Pages: 759-769

Published online: 31 Mar 2010

AbstractforSafety of amide local anesthetics: new trends | Full Text | References | PDF (259.5 KB)

210 Views
1 CrossRef citations
0Altmetric

Article

The genetic toxicity effects of lamivudine and stavudine antiretroviral agents

Nilza Nascimento Guimarães, Heloísa Helena Rodrigues de Andrade, Maurício Lehmann, Rafael Rodrigues Dihl & Kênya Silva Cunha

Pages: 771-781

Published online: 09 Apr 2010

AbstractforThe genetic toxicity effects of lamivudine and stavudine antiretroviral agents | Full Text | References | PDF (240.8 KB)

269 Views
9 CrossRef citations
0Altmetric

Drug Safety Evaluations

Article

The cardiovascular risk of tiotropium: is it real?

Mario Cazzola, Luigino Calzetta & Maria Gabriella Matera

Pages: 783-792

Published online: 21 Jun 2010

AbstractforThe cardiovascular risk of tiotropium: is it real? | Full Text | References | PDF (260.4 KB)

342 Views
17 CrossRef citations
0Altmetric

Article

Safety of fluvastatin in patients undergoing high-risk non-cardiac surgery

Michiel T Voûte MD, Tamara A Winkel MD & Don Poldermans MD PhD

Pages: 793-800

Published online: 17 Jun 2010

AbstractforSafety of fluvastatin in patients undergoing high-risk non-cardiac surgery | Full Text | References | PDF (215.2 KB)

162 Views
5 CrossRef citations
0Altmetric

Article

Safety evaluation of tirofiban

Marco Valgimigli MD PhD & Matteo Tebaldi MD

Pages: 801-819

Published online: 30 Jul 2010

AbstractforSafety evaluation of tirofiban | Full Text | References | PDF (405.4 KB)

242 Views
5 CrossRef citations
0Altmetric

Article

Safety evaluation of telbivudine

David Yiu-Kuen But MBBS MRCP FHKCP FHKAM (Med),, Man-Fung Yuen MBBS MD PhD FRCP (London, Edinburgh, Glasgow) FHKCP FHKAM (Med),, James Fung MBChB FHKCP FHKAM (Med) FRACP & Ching-Lung Lai MD FRCP (London, Edinburgh, Glasgow), FRACP FHKCP FHKAM (Med)

Pages: 821-829

Published online: 27 Jul 2010

AbstractforSafety evaluation of telbivudine | Full Text | References | PDF (238.4 KB)

341 Views
23 CrossRef citations
0Altmetric

Article

Safety of capecitabine: a review

Sameh E Mikhail MD, Jun F Sun MD & John L Marshall MD

Pages: 831-841

Published online: 19 Aug 2010

AbstractforSafety of capecitabine: a review | Full Text | References | PDF (242.7 KB)

1049 Views
60 CrossRef citations
0Altmetric

Article

Everolimus: efficacy and safety in cardiac transplantation

S Allan Schaffer & Heather J Ross

Pages: 843-854

Published online: 12 Aug 2010

AbstractforEverolimus: efficacy and safety in cardiac transplantation | Full Text | References | PDF (324.2 KB)

534 Views
30 CrossRef citations
0Altmetric

Meeting Highlights

Article

Cardiovascular system assessment best practices: a Safety Pharmacology Society meeting

11 – 12 May 2010, Cambridge, MA, USA

Icilio Cavero PhD

Pages: 855-866

Published online: 08 Aug 2010

AbstractforCardiovascular system assessment best practices: a Safety Pharmacology Society meeting | Full Text | References | PDF (234.1 KB)

119 Views
14 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database

Yu Sun et al.

Article | Published online: 16 May 2024

Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system

Zhou Zhu et al.

Article | Published online: 14 May 2024

Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile

André J. Scheen

Review Article | Published online: 13 May 2024

Differences in Ocular Adverse Events Associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study

Zhiwen Fu et al.

Article | Published online: 13 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.9, Iss.5, 2010)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?